Alexion Pharmaceuticals Inc.
ALXN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$40.17B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $40.17 Billion |
|---|---|
| Enterprise Value | $39.23 Billion |
| Earnings per Share | $2.75 |
| Beta | 1.26 |
| Outstanding Shares | 220,100,000 |
Return
| Return on Equity | 5.49% |
|---|---|
| Return on Assets | 3.66% |
| Return on Invested Capital | 17.11% |
Valuation & Multiples
| P/E Ratio | 66.36 |
|---|---|
| PEG | 471.99 |
| Price to Sales | 6.52 |
| Price to Book Ratio | 3.26 |
| Enterprise Value to Revenue | -0.15 |
| Enterprise Value to EBIT | -0.32 |
| Enterprise Value to Net Income | 57 |
| Total Debt to Enterprise | -2.7 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Alexion Pharmaceuticals Inc.
CEO: Leonard Bell
